propranolol has been researched along with Hyperhomocysteinemia in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with a history of venous thrombosis and mutations in genes encoding for coagulation factors (factor V Leiden, factor II, G20210A) do not have an enhanced risk of recurrence and, thus, do not qualify for extended secondary thromboprophylaxis." | 2.42 | The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism. ( Eichinger, S; Kyrle, PA, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kyrle, PA | 1 |
| Eichinger, S | 1 |
1 review available for propranolol and Hyperhomocysteinemia
| Article | Year |
|---|---|
The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism.
Topics: Adolescent; Adrenergic beta-Antagonists; Anticoagulants; Cohort Studies; Factor IX; Factor VIII; Fac | 2003 |